NO323556B1 - Forbindelser, farmasoytiske preparater som omfatter forbindelsene, og anvendelse av forbindelsene ved fremstilling av antibakterielle medikamenter. - Google Patents

Forbindelser, farmasoytiske preparater som omfatter forbindelsene, og anvendelse av forbindelsene ved fremstilling av antibakterielle medikamenter.

Info

Publication number
NO323556B1
NO323556B1 NO20020804A NO20020804A NO323556B1 NO 323556 B1 NO323556 B1 NO 323556B1 NO 20020804 A NO20020804 A NO 20020804A NO 20020804 A NO20020804 A NO 20020804A NO 323556 B1 NO323556 B1 NO 323556B1
Authority
NO
Norway
Prior art keywords
compounds
present
prevention
treatment
bacterial infections
Prior art date
Application number
NO20020804A
Other languages
English (en)
Other versions
NO20020804D0 (no
NO20020804L (no
Inventor
Hitoshi Hotoda
Satoshi Ohya
Yukio Utsui
Masatoshi Inukai
Masakatsu Kaneko
Yasunori Muramatsu
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20020804D0 publication Critical patent/NO20020804D0/no
Publication of NO20020804L publication Critical patent/NO20020804L/no
Publication of NO323556B1 publication Critical patent/NO323556B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20020804A 1999-08-20 2002-02-19 Forbindelser, farmasoytiske preparater som omfatter forbindelsene, og anvendelse av forbindelsene ved fremstilling av antibakterielle medikamenter. NO323556B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23393499 1999-08-20
PCT/JP2000/005538 WO2001014399A1 (fr) 1999-08-20 2000-08-18 Nouveaux derives a-500359

Publications (3)

Publication Number Publication Date
NO20020804D0 NO20020804D0 (no) 2002-02-19
NO20020804L NO20020804L (no) 2002-04-19
NO323556B1 true NO323556B1 (no) 2007-06-11

Family

ID=16962911

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020804A NO323556B1 (no) 1999-08-20 2002-02-19 Forbindelser, farmasoytiske preparater som omfatter forbindelsene, og anvendelse av forbindelsene ved fremstilling av antibakterielle medikamenter.

Country Status (25)

Country Link
US (1) US7157442B2 (no)
EP (1) EP1209166B1 (no)
KR (1) KR100787849B1 (no)
CN (1) CN1176936C (no)
AT (1) ATE263183T1 (no)
AU (1) AU763492B2 (no)
BR (1) BR0013435A (no)
CA (1) CA2382654C (no)
CZ (1) CZ2002682A3 (no)
DE (1) DE60009517T2 (no)
DK (1) DK1209166T3 (no)
ES (1) ES2216933T3 (no)
HK (1) HK1044951A1 (no)
HU (1) HUP0204217A3 (no)
IL (2) IL148196A0 (no)
MX (1) MXPA02001817A (no)
NO (1) NO323556B1 (no)
NZ (1) NZ517315A (no)
PL (1) PL353494A1 (no)
PT (1) PT1209166E (no)
RU (1) RU2227799C2 (no)
TR (1) TR200200485T2 (no)
TW (1) TWI245047B (no)
WO (1) WO2001014399A1 (no)
ZA (1) ZA200201409B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID27955A (id) * 1998-07-09 2001-05-03 Sankyo Co Senyawa-senyawa antimikroba yang baru
US7652039B2 (en) * 2002-05-17 2010-01-26 Sequella, Inc. Methods of use and compositions for the diagnosis and treatment of infectious disease
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
WO2005034857A2 (en) * 2003-09-05 2005-04-21 Sequella, Inc. Methods and compositions comprising diamines as new anti-tubercular therapeutics
US20090281054A1 (en) * 2008-05-06 2009-11-12 Venkata Reddy Compositions and methods comprising capuramycin analogues
KR101104505B1 (ko) * 2010-01-30 2012-01-12 김근섭 호스 연결용 원클릭 피팅
WO2015027137A1 (en) * 2013-08-23 2015-02-26 University Of Tennessee Research Foundation Improved synthesis of capuramycin and its analogues
WO2022006231A1 (en) * 2020-06-30 2022-01-06 University Of Tennessee Research Foundation Dpagt1 inhibitors of capuramycin analogues and their antimigratory activities of solid tumors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60259190A (ja) * 1984-06-06 1985-12-21 Kanto Ishi Pharma Co Ltd 新抗生物質カプラマイシン及びその製造法
US5034381A (en) 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
JPH05148293A (ja) * 1991-11-28 1993-06-15 Mect Corp 新規カプラマイシン誘導体およびその製造方法
GB9307043D0 (en) 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
JP4428762B2 (ja) 1998-07-09 2010-03-10 セケラ インコーポレイテッド 抗生物質ａ−５００３５９及び誘導体
ID27955A (id) 1998-07-09 2001-05-03 Sankyo Co Senyawa-senyawa antimikroba yang baru
JP4531167B2 (ja) 1998-09-24 2010-08-25 セケラ インコーポレイテッド 新規抗細菌化合物
JP4960548B2 (ja) * 2000-01-07 2012-06-27 セケラ インコーポレイテッド 新規抗細菌化合物の用途
JP5022539B2 (ja) 2000-01-07 2012-09-12 セケラ インコーポレイテッド 抗生物質ａ−５００３５９及び誘導体を含有する抗菌剤

Also Published As

Publication number Publication date
CA2382654A1 (en) 2001-03-01
NZ517315A (en) 2004-02-27
AU763492B2 (en) 2003-07-24
KR100787849B1 (ko) 2007-12-27
DE60009517D1 (de) 2004-05-06
US20030171330A1 (en) 2003-09-11
US7157442B2 (en) 2007-01-02
CN1176936C (zh) 2004-11-24
HUP0204217A2 (en) 2003-03-28
CZ2002682A3 (cs) 2002-06-12
HK1044951A1 (en) 2002-11-08
CA2382654C (en) 2009-01-13
ES2216933T3 (es) 2004-11-01
ZA200201409B (en) 2003-07-30
IL148196A0 (en) 2002-09-12
TR200200485T2 (tr) 2002-06-21
IL148196A (en) 2008-06-05
EP1209166A1 (en) 2002-05-29
KR20020092901A (ko) 2002-12-12
PL353494A1 (en) 2003-11-17
CN1382152A (zh) 2002-11-27
EP1209166A4 (en) 2002-10-09
EP1209166B1 (en) 2004-03-31
DK1209166T3 (da) 2004-07-26
DE60009517T2 (de) 2005-01-13
NO20020804D0 (no) 2002-02-19
WO2001014399A1 (fr) 2001-03-01
AU6595500A (en) 2001-03-19
NO20020804L (no) 2002-04-19
ATE263183T1 (de) 2004-04-15
PT1209166E (pt) 2004-06-30
RU2227799C2 (ru) 2004-04-27
TWI245047B (en) 2005-12-11
HUP0204217A3 (en) 2005-11-28
BR0013435A (pt) 2002-07-16
MXPA02001817A (es) 2002-08-12

Similar Documents

Publication Publication Date Title
PT842923E (pt) Derivados do pirrolo e composicoes medicinais
NO323556B1 (no) Forbindelser, farmasoytiske preparater som omfatter forbindelsene, og anvendelse av forbindelsene ved fremstilling av antibakterielle medikamenter.
DE60123827D1 (en) 1-methylcarbapenemderivate
IL169577A0 (en) Oligosaccharide derivatives and pharmaceutical compostions containing the same
EE05007B1 (et) 9a-N-(N'-arlkarbamol)- ja 9a-N-(N'-arltiokarbamol)-9-desokso-9a-asa-9a-homoertromtsiini Ahalogeenderivaadid, nende valmistamismeetod, farmatseutiline kompositsioon ja kasutamine
WO2000078793A3 (en) Antimicrobial agents
DE69424677T2 (de) Präparat zur behandlung der drogenabhängigkeit

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees